Baxter to pay common stock dividend to holders of record as of 3 December 2021

Moderna Inc to donate COVID-19 vaccine via EU and EEA to COVAX for low and middle-income countries

Pfizer signs licensing agreement with UN-backed MPP to allow generic versions of its COVID-19 pill in 95 countries

Moderna Posts Positive Data from Phase 2 Study of mRNA VEGF-A Therapeutic in Patients Undergoing Coronary Artery Bypass Grafting Surgery

AgeX Therapeutics incurs lower net loss of USD1.956m for Q3 2021

Japanese Government to Purchase 1.6m Courses of Molnupiravir, an Investigational Oral COVID-19 Antiviral Medicine, Upon Authorization or Approval

Inventprise Gains Investment of Up to USD 90m to Advance its 25 Valent Pneumococcal Conjugate Vaccine Candidate into Proof-of-Concept Clinical Trials

BioNTech expects EUR17bn in revenues from COVID-19 vaccine in 2021

BioNet and Sartorius' BIA Separations Collaborate on Production Process Development of mRNA Vaccines

Merck has signed eight deals for selling in total two million doses of its anti-viral COVID-19 pill

Bio-Techne announces dividend of USD0.32 per share

Perrigo's board of directors announce quarterly dividend

Global COVID-19 deaths pass five million

Moderna to Supply Additional Doses of COVID-19 Vaccine Per New Gavi Deal

Pfizer, BioNTech to Provide US Government an Additional 50m Pediatric Doses of COVID-19 Vaccine to Support Further Preparedness for Future Needs